- Home
- ADBE vs BMY Comparison
ADBE vs BMY Comparison
Compare ADBE & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADBE
- BMY
- Stock Information
- Founded
- ADBE 1982
- BMY 1887
- Country
- ADBE United States
- BMY United States
- Employees
- ADBE N/A
- BMY N/A
- Industry
- ADBE Computer Software: Prepackaged Software
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- ADBE Technology
- BMY Health Care
- Exchange
- ADBE Nasdaq
- BMY Nasdaq
- Market Cap
- ADBE 156.7B
- BMY 120.5B
- IPO Year
- ADBE 1986
- BMY N/A
- Fundamental
- Price
- ADBE $383.99
- BMY $46.88
- Analyst Decision
- ADBE Buy
- BMY Hold
- Analyst Count
- ADBE 24
- BMY 16
- Target Price
- ADBE $520.68
- BMY $58.93
- AVG Volume (30 Days)
- ADBE 3.3M
- BMY 16.6M
- Earning Date
- ADBE 06-12-2025
- BMY 04-24-2025
- Dividend Yield
- ADBE N/A
- BMY 5.29%
- EPS Growth
- ADBE 44.73
- BMY N/A
- EPS
- ADBE 15.16
- BMY 2.67
- Revenue
- ADBE $22,037,000,000.00
- BMY $47,636,000,000.00
- Revenue This Year
- ADBE $11.18
- BMY N/A
- Revenue Next Year
- ADBE $9.69
- BMY N/A
- P/E Ratio
- ADBE $25.32
- BMY $17.55
- Revenue Growth
- ADBE 10.54
- BMY 4.62
- 52 Week Low
- ADBE $332.01
- BMY $39.35
- 52 Week High
- ADBE $587.75
- BMY $63.33
- Technical
- Relative Strength Index (RSI)
- ADBE 58.28
- BMY 31.46
- Support Level
- ADBE $375.05
- BMY $48.69
- Resistance Level
- ADBE $363.00
- BMY $50.65
- Average True Range (ATR)
- ADBE 8.04
- BMY 1.41
- MACD
- ADBE 4.94
- BMY 0.11
- Stochastic Oscillator
- ADBE 90.54
- BMY 8.60
About ADBE Adobe Inc.
Adobe provides content creation, document management, and digital marketing and advertising software and services to creative professionals and marketers for creating, managing, delivering, measuring, optimizing, and engaging with compelling content multiple operating systems, devices, and media. The company operates with three segments: digital media content creation, digital experience for marketing solutions, and publishing for legacy products (less than 5% of revenue).
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.